Waterwood
水木未来
elsewhere's corpus does not cover Waterwood Capital as a subject in its own right. The bundle contains only passing mentions of Waterwood (水木创投 / Waterwood Capital) as a co-investor or follow-on investor in deals led by others—specifically, it re-upped in Saiqiao Biotech's Series B , joined Booster Robotics' Pre-A , and both followed and added to ENCOS's rounds . These citations name Waterwood but do not describe its vintage, size, strategy, or team. No entity card or chunk in the bundle profiles the fund itself.
AI-generated — may contain errors, please verify.
Coverage
Millions of Dollars per Unit: How Shuimu Biosciences Plans to Slash Cryo-EM Costs with "AI plus Domestic Manufacturing" | Gaorong Future
Scaling the Summit of Domestic Cryo-EM Manufacturing.
At the Intersection of Generative AI and Life Sciences: Technology Acceleration on One Side, Clinical Demand on the Other | Ronghui x NVIDIA Inception Program
NVIDIA, Gaorong Ventures, and Cornerstone Robotics on the Acceleration of "AI + Healthcare"
Rongbao · May | Large-Memory Computing, Autonomous Driving and Other New Technologies Accelerate Adoption; Integration of Goods and Services Emerges as New Consumption Trend
Underlying technological innovation and new demographics are driving infinite possibilities.
Shuimu BioSciences Announces Angel Round to Build World-Class Next-Generation Drug Discovery Platform
Shuimu BioSciences has built Asia's first commercial protein structure analysis platform centered on 300kV top-tier cryo-EM, dedicated to using breakthrough technology to dramatically accelerate drug discovery and improve the druggability of difficult targets.
